Abstract
Recombinant protein therapy from Chinese Hamster Ovary (CHO) cell has brought significant improvement in the healthcare services. CHO cell continues to be used for recombinant protein therapy, as it is adaptable to various cell culture conditions and plasticity, to perform genetic alterations. Recombinant protein therapy continues to provide innovative and effective therapies for several refractory diseases. The protein therapy from CHO cells is being used for treating a variety of human diseases, including cancers and infertility. These proteins are synthesized by large-scale cultivation of genetically engineered cells, which contain artificially transfected genes encoding for the proteins for specific requirements. The proteins need to be synthesized in biologically active forms, for protein therapy to be effective.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 40-47 |
| Number of pages | 8 |
| Journal | Chemical Engineering Progress |
| Volume | 103 |
| Issue number | 10 |
| State | Published - Oct 2007 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Recombinant protein therapeutics from CHO Cells - 20 years and counting'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS